YOLFTbeta
30

Chongqing Lummy Pharmaceutical

300006 · SHE · Healthcare / Drug Manufacturers - General

11.34CNY-0.49 (-4.14%)

Price History

Full chart

Market Stats

Previous Close11.83
Open11.98
Day Range11.19 – 12.68
52-Week Range4.10 – 6.86
Volume197.05M
Market Cap5.87B
P/E (TTM)0.00
Forward P/E72.46
EPS-0.12
Dividend Yield0.00%
Beta0.43
50-Day Avg5.30
200-Day Avg5.33

About

Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It provides anti-tumor, anti-inflammatory, antibacterial, digestive, anti-virus, blood system, cardiovascular system, acid-base balance nutritional medicine, endocrine system drugs, tumor adjuvant medication, antifungal, and opioid receptor antagonists. The company was founded in 1999 and is headquartered in Chongqing, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • CEOMr. Rongzhao Qiu
  • Employees973
  • HeadquartersBuilding B, Huangshan Avenue, Chongqing, China, 401121, China
  • Websitehttps://www.cqlummy.com

Leadership

  • Mr. Rongzhao QiuGeneral Manager · b. 1994
  • Mr. Xue Feng LengDeputy GM & Vice Chairman · b. 1972
  • Ms. Wen LaiFinancial Director · b. 1974
  • Mr. Dan CuiDeputy GM, Secretary & General Counsel · b. 1980
  • Mr. Song LinDeputy GM & Director · b. 1973
  • Ms. Ruoyue WangDeputy GM & GM of Chemical Pharmaceutical Division · b. 1959

Financials

Income Statement

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue96.47M166.06M265.22M333.54M377.65M534.09M631.46M759.12M911.80M963.98M990.22M1.28B1.56B1.86B1.58B1.23B884.59M895.59M795.60M768.97M
Growth (%)-+72.12%+59.72%+25.76%+13.22%+41.43%+18.23%+20.22%+20.11%+5.72%+2.72%+29.47%+21.86%+18.99%-14.82%-22.63%-27.80%+1.24%-11.17%-3.35%
Cost of Revenue56.51M106.23M169.46M212.51M239.62M334.22M379.21M474.10M623.70M613.04M587.10M661.21M620.35M542.86M526.96M380.93M238.66M283.15M296.54M379.89M
Gross Profit39.96M59.82M95.76M121.04M138.03M199.87M252.26M285.02M288.10M350.94M403.12M620.86M942.02M1.32B1.06B844.30M645.93M612.44M499.06M389.07M
Gross Margin41.42%36.02%36.11%36.29%36.55%37.42%39.95%37.55%31.60%36.41%40.71%48.43%60.29%70.80%66.72%68.91%73.02%68.38%62.73%50.60%
Operating Expense31.03M30.26M60.58M75.97M90.48M133.84M198.80M204.31M283.36M334.41M409.78M572.56M832.52M1.49B1.40B914.44M741.97M556.21M604.88M490.67M
Operating Income8.93M29.56M35.18M45.07M47.54M66.04M53.46M80.71M4.74M16.53M-6.66M48.30M109.50M-168.93M-346.09M-70.14M-96.04M56.23M-105.82M-101.60M
Operating Margin9.26%17.80%13.26%13.51%12.59%12.36%8.47%10.63%0.52%1.71%-0.67%3.77%7.01%-9.09%-21.86%-5.72%-10.86%6.28%-13.30%-13.21%
EBITDA18.87M33.91M47.18M60.25M64.90M125.25M118.56M158.75M137.06M191.37M146.39M192.87M276.76M14.10M-148.63M-3.87M15.85M81.65M-15.29M-47.73M
EBITDA Margin19.56%20.42%17.79%18.06%17.19%23.45%18.78%20.91%15.03%19.85%14.78%15.04%17.71%0.76%-9.39%-0.32%1.79%9.12%-1.92%-6.21%
Net Income8.54M24.49M32.89M40.47M43.87M73.09M53.71M60.81M9.28M20.61M6.98M55.56M98.00M-155.20M-326.76M-100.53M-68.71M-8.93M-87.80M-134.71M
Net Income Margin8.86%14.75%12.40%12.13%11.62%13.68%8.51%8.01%1.02%2.14%0.71%4.33%6.27%-8.35%-20.64%-8.20%-7.77%-1.00%-11.04%-17.52%
R&D----24.17M16.31M15.63M18.37M27.31M29.59M26.66M33.72M42.74M164.04M107.36M100.20M80.65M99.81M76.49M61.18M
R&D as % of Total Revenue----6.40%3.05%2.48%2.42%3.00%3.07%2.69%2.63%2.74%8.82%6.78%8.18%9.12%11.14%9.61%7.96%
Interest Expense1.05M2.33M4.75M4.24M4.22M14.20M22.47M32.62M50.86M61.05M33.01M37.52M60.03M75.31M86.19M32.26M20.50M12.59M11.23M13.88M
Interest Expense % of Total Revenue1.09%1.40%1.79%1.27%1.12%2.66%3.56%4.30%5.58%6.33%3.33%2.93%3.84%4.05%5.44%2.63%2.32%1.41%1.41%1.81%

Balance Sheet

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets125.10M214.69M268.56M653.63M884.01M1.08B1.42B2.18B2.24B3.10B2.48B2.74B3.14B3.50B3.15B2.93B3.05B2.89B2.86B2.57B
Total Liabilities60.72M106.78M130.77M128.55M322.42M420.81M713.21M1.06B1.23B1.41B809.85M1.02B1.42B1.85B1.92B714.65M870.02M768.71M972.47M806.20M
Total Equity64.25M107.65M137.79M525.08M559.80M624.39M659.80M1.10B994.08M1.64B1.63B1.69B1.70B1.56B1.17B2.16B2.12B2.08B1.88B1.76B
Cash7.46M36.12M29.25M396.85M187.78M123.91M140.11M434.44M146.80M819.00M183.06M213.76M314.64M436.73M544.91M559.43M846.29M836.44M1.07B881.47M
Total Debt30.00M33.10M47.30M54.40M126.50M284.61M351.30M563.20M768.01M998.50M530.95M555.81M881.49M1.25B1.16B194.66M365.27M242.53M388.19M378.86M
Net Debt22.54M-3.02M18.05M-342.45M-61.28M160.70M211.19M128.76M621.21M179.50M347.89M342.05M566.84M810.24M613.25M-364.77M-481.02M-562.44M-683.91M-502.61M

Cash Flow

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow7.77M21.68M17.25M37.35M37.66M11.85M18.18M74.70M-49.38M-25.41M125.66M61.39M225.89M231.30M224.54M108.28M57.13M81.53M185.03M61.31M
Investing Cash Flow-20.04M-19.82M-25.36M-18.68M-265.91M-198.13M-162.60M-335.59M-237.03M-140.03M-182.45M-116.70M-319.19M-88.01M-110.97M157.19M13.82M-119.52M-18.31M-55.60M
Financing Cash Flow11.20M15.77M12.52M345.70M11.47M132.91M149.35M520.42M25.06M833.46M-561.97M56.33M107.38M-132.63M-61.37M36.05M166.07M-81.24M189.94M-149.05M
Capital Expenditure15.54M18.43M25.10M18.74M98.97M135.10M177.33M355.40M153.91M55.19M76.98M21.23M125.93M63.07M43.58M38.66M68.18M59.32M75.51M38.16M
Free Cash Flow-7.77M3.25M-7.86M18.61M-61.32M-123.25M-159.15M-280.71M-203.30M-80.59M48.68M40.15M99.95M168.23M180.96M69.63M-11.05M22.21M109.52M23.16M
Dividends Paid1.11M2.24M7.21M6.98M13.36M26.28M40.84M57.92M69.43M70.88M55.39M74.73M93.90M40.61M40.61M29.08M17.47M11.80M10.76M12.35M
FCF to OCF-100.07%14.97%-45.56%49.83%-162.82%-1040.03%-875.30%-375.81%411.67%317.21%38.74%65.41%44.25%72.73%80.59%64.30%-19.34%27.24%59.19%37.77%
Dividend Paid to FCF-14.29%69.02%-91.82%37.51%-21.79%-21.32%-25.66%-20.63%-34.15%-87.95%113.78%186.11%93.94%24.14%22.44%41.77%-158.05%53.14%9.83%53.31%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Nov 30, 2011Mar 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Oct 23, 2014Jan 12, 2015Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 2, 2016Apr 22, 2016Jul 29, 2016Oct 28, 2016Apr 21, 2017Aug 24, 2017Oct 13, 2017Feb 28, 2018Apr 23, 2018Aug 24, 2018Oct 19, 2018Apr 24, 2019Aug 29, 2019Oct 27, 2019Apr 25, 2020Aug 29, 2020Oct 28, 2020Apr 24, 2021Jul 30, 2021Oct 28, 2021Mar 25, 2022Apr 27, 2022Aug 26, 2022Oct 26, 2022Mar 11, 2023Apr 22, 2023Aug 24, 2023Oct 21, 2023Mar 23, 2024Apr 12, 2024Aug 24, 2024Oct 23, 2024Apr 11, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------0.03-----------------------------------------------------
EPS Actual0.020.020.010.020.030.040.02-0.010.030.020.020.010.030.020.010.02-0.03-0.010.010.040.010.010.000.010.020.020.020.030.030.02-0.010.060.040.02-0.000.040.03-0.280.000.01-0.40-0.02-0.01-0.09-0.03-0.020.01-0.03-0.00-0.05-0.000.04-0.000.01-0.03-0.01-0.02-0.01-0.08-0.01-0.01
Surprise--------133.33%-----------------------------------------------------
Timing-------After-hours----------After-hoursAfter-hours----Pre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-------After-hours--After-hours-----

Key Statistics & Ratios

Market Cap5.87B
Enterprise Value5.34B
Trailing P/E0.00
Forward P/E72.46
PEG Ratio0.00
Price / Sales7.84
Price / Book3.43
EPS-0.12
Book Value1.64
Revenue (TTM)748.94M
Gross Profit (TTM)394.14M
EBITDA-22.91M
Profit Margin-16.92%
Operating Margin-1.37%
Return on Equity-6.65%
Return on Assets-1.55%
Shares Outstanding1.06B
Shares Float697.66M
Beta0.43
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20201×
0.05Jul 3, 2020
20191×
0.05Jul 12, 2019
20181×
0.05Aug 22, 2018
20171×
0.05Jul 5, 2017
20161×
0.03May 24, 2016
20151×
0.03Jul 15, 2015
20141×
0.03Aug 13, 2014
20131×
0.03Aug 13, 2013
20121×
0.03Jun 20, 2012
20111×
0.01Jul 12, 2011
20101×
0.01Jun 25, 2010

Stock Splits

  • May 24, 201636:10
  • Jul 12, 20112:1